Screener
Capricor Therapeutics CAPR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
FAQ
- What is Capricor Therapeutics's invested capital?
- Capricor Therapeutics (CAPR) reported invested capital of $188.07M in Q1 2026.
- How has Capricor Therapeutics's invested capital changed year-over-year?
- Capricor Therapeutics's invested capital increased by 87.9% year-over-year, from $100.1M to $188.07M.
- What is the long-term trend for Capricor Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Capricor Therapeutics's invested capital has grown at a 49.2% compound annual growth rate (CAGR), from -$4.39M to $32.47M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Capricor Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude